Q2 2026 Earnings - Press Kit & Media Assets

Access comprehensive materials for the Q2 2026 financial results, including press releases, reports, and media resources.


Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Teva Investor Q2 2026 Call Summary

Key takeaways from Teva's second-quarter shareholder update, from financial performance and pipeline progress to the milestones ahead.  

Q2 Earnings Highlights

Our transformation at a glance. Innovative portfolio momentum, pipeline progress, strategic execution. Get the full readout on our progress in just 5 minutes with this AI-powered recap.

*This summary was generated with the assistance of AI tools based on the Q2 2026 earnings call transcript. While reviewed for accuracy, it may contain errors or interpretations not intended by Teva. For the official record, please refer to the full earnings call transcript here: https://ir.tevapharm.com/financials/quarterly-results/default.aspx

Forward-looking statements are subject to the cautionary note included in our Q2 2026 press release.

Download Materials - Q2 2026 Earnings

Quarterly Results

Contacts for Media Inquiries

United States

 

tel: +1-973-2653670

Israel & Corporate

Email
 

tel: +972-3-9062645

Europe

Email